TLDR Hair mass index is a precise way to measure hair loss in chemotherapy patients.
The study evaluated the efficacy of using the hair mass index (HMI) obtained by cross-section trichometry (CST) to quantify hair in patients with chemotherapy-induced alopecia (CIA). Ten chemotherapy patients were measured, and their hair loss was assessed using CST, WHO grade, VAS score, and the need for wigs or head covers. Hair loss ranged from 13% to 82%, with 50% of patients needing wigs or head covers. The study found that CST for HMI measurement was a precise method for assessing hair loss, more so than non-mechanical methods. Marking the measurement site on the scalp was deemed necessary only when minor changes in hair quantity were expected.
13 citations,
January 2012 in “Dermatologic surgery” The trichometer is a quick and reliable tool for measuring hair quantity.
62 citations,
February 2011 in “Expert review of dermatology” Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.
155 citations,
March 2009 in “Seminars in Cutaneous Medicine and Surgery” Scalp cooling might reduce hair loss from chemotherapy, but evidence is weak and other treatments are being tested.
29 citations,
March 2008 in “Dermatologic Surgery” The Cross-section Trichometer is a new tool that can measure hair quantity and detect hair loss and growth.
January 2015 in “Hair therapy & transplantation” New hair and scalp disease diagnosis methods are important for correct treatment.
8 citations,
February 2018 in “European journal of oncology nursing” The Hair Check tool can measure hair loss, but patients' own reports are more reliable for assessing hair loss during chemotherapy.
9 citations,
March 2020 in “Dermatologic Surgery” Both Follicular Unit Transplantation (FUT) and Follicular Unit Excision (FUE) are effective hair transplant methods; the best choice depends on the patient's needs and the surgeon's preference.
June 2024 in “Journal of clinical oncology” Scalp cooling can effectively prevent hair loss during chemotherapy, improving patients' quality of life.
21 citations,
May 2016 in “The Cochrane library” Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.
